Covid-19 roundup: Pfizer submits vaccine for full approval; Merkel opposes Biden proposal to suspend IP for vaccines

Zachary Brennan

Senior Editor

Pfizer and BioNTech said Friday that they’ve submitted a biologics license application to the FDA for full approval of their mRNA vaccine for those over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Pfizer submits vaccine for full approval; Merkel opposes Biden proposal to suspend IP for vaccines

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Boehringer’s updated results in HER2-mutated lung cancer impress

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Covid-19 roundup: Pfiz­er sub­mits vac­cine for full ap­proval; Merkel op­pos­es Biden pro­pos­al to sus­pend IP for vac­cines

Senior Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Covid-19 roundup: Pfizer submits vaccine for full approval; Merkel opposes Biden proposal to suspend IP for vaccines